Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AER Compliance Will Require Preparation, Preparation, Preparation – AHPA

This article was originally published in The Tan Sheet

Executive Summary

Some dietary supplement firms plan to hire contractors to handle consumers' adverse event reports, but most firms will not need outside help if they properly prepare for collecting AERs, industry experts said during a training seminar Feb. 22

You may also be interested in...



Experts Give AER Prep Course, Discuss Potential Potholes At UNPA Seminar

The implementation of the adverse event reporting bill will present the dietary supplement and nonprescription drug industries with challenges as well as opportunities, experts stressed at a recent United Natural Products Alliance seminar on the implementation of the new law

Products Distributed In Bulk Could Pump Up Already Large OTC Sanitizer Problem In US

“Regardless of whether the adulterated products are sold on store shelves, online to consumers, or in bulk format to businesses and other organizations, FDA’s priority is safety," says American Cleaning Institute VP James Kim.

US COVID-19 Claim Warnings Continue; Hi-Tech’s Problems Extend To Undeclared Allergens

Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.

Topics

UsernamePublicRestriction

Register

PS100265

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel